Charoen Pokphand Indonesia TBK PT (CPIN)
Jakarta Exchange · Indonesia · prices in IDR · close of 19 Oct 2026
Key indicators
| Last close | IDR 2,440.00 |
|---|---|
| 52-week range | 2,390.00 – 5,136.70 |
| Return, 1 month / 3 months | −22.5% / −24.0% |
| Return, 1 year / 3 years | −48.3% / −46.8% |
| Trend | Below its 200-day average |
| RSI (14) | 21 |
| Volatility (1 year) | 41.1% |
| Worst drawdown (1 year) | -51.1% |
| Average daily value traded | 92,174.18M IDR |
| Dividend yield | 7.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Charoen Pokphand Indonesia is an Indonesian agribusiness company based in Jakarta. It makes animal feed for poultry, swine and fish, and it runs poultry operations that supply day-old chicks and processed chicken. Its customers include livestock and aquaculture farmers as well as food businesses that rely on its feed and poultry products. The company is part of the Charoen Pokphand group and serves Indonesia's domestic farming and food markets.
Charoen Pokphand Indonesia TBK PT trades under the code CPIN on the Jakarta Exchange in Indonesia, with its price quoted in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Charoen Pokphand Indonesia TBK PT (CPIN) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 2,440.00 on 19 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 453 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 48.3% and over the last three months it fell 24.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 30 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -32.2% | ||
| From 52-week high | -51.1% | ||
| Momentum | 24 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -24.0% | ||
| 6-month return | -38.3% | ||
| 12-month return, skipping the last month | -33.3% | ||
| Risk (lower is better) | 63 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 41.1% | ||
| Worst drawdown (1 year) | -51.1% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 92,174.18M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 71 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 7.4% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −19.2% |
|---|---|
| 1 month | −22.5% |
| 3 months | −24.0% |
| 6 months | −38.3% |
| 1 year | −48.3% |
| 3 years | −46.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 3,032.80 / 3,596.69 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 112.25 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Jun 2026 | IDR 180.0000 |
| 3 Jun 2025 | IDR 108.0000 |
| 3 Jun 2024 | IDR 30.0000 |
| 17 Nov 2023 | IDR 100.0000 |
| 3 Jun 2022 | IDR 108.0000 |
| 4 Aug 2021 | IDR 112.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.